Highbridge Capital Management’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Hold |
0
| – | – | – | 790 |
|
|
2017
Q3 | – | Hold |
0
| – | – | – | 795 |
|
|
2017
Q2 | – | Sell |
-68,097
| Closed | -$572K | – | 854 |
|
|
2017
Q1 | $572K | Buy |
+68,097
| New | +$572K | 0.01% | 677 |
|
|
2016
Q4 | – | Sell |
-176,962
| Closed | -$780K | – | 1006 |
|
|
2016
Q3 | $780K | Buy |
176,962
+44,674
| +34% | +$197K | 0.01% | 563 |
|
|
2016
Q2 | $376K | Buy |
132,288
+111,755
| +544% | +$318K | 0.01% | 756 |
|
|
2016
Q1 | $58K | Buy |
+20,533
| New | +$58K | ﹤0.01% | 772 |
|
|
2015
Q3 | – | Sell |
-137,042
| Closed | -$2.05M | – | 900 |
|
|
2015
Q2 | $2.05M | Buy |
137,042
+99,525
| +265% | +$1.49M | 0.03% | 398 |
|
|
2015
Q1 | $339K | Buy |
+37,517
| New | +$339K | ﹤0.01% | 641 |
|
|
2014
Q4 | – | Sell |
-32,797
| Closed | -$321K | – | 758 |
|
|
2014
Q3 | $321K | Sell |
32,797
-49,749
| -60% | -$487K | ﹤0.01% | 712 |
|
|
2014
Q2 | $1.05M | Buy |
+82,546
| New | +$1.05M | 0.01% | 413 |
|